Variable | AS exposure | p Value | |
No (n=360) | Yes (n=765) | ||
Time to clinical stability (days) | 3.54 (SD 3.34) | 4.75 (SD 3.80) | p<0.001 |
Time to oral intake (days) | 2.14 (SD 2.06) | 2.39 (SD 1.90) | p=0.054 |
Phase 1 (n=517) | Phase 2 (n=248) | ||
Time to AS intervention (days) | 2.87 (SD 1.11) | 2.59 (SD 1.67) | p=0.016 |
AS, antimicrobial stewardship.